Cite
MLA Citation
Vana Kolovou et al.. “Lipoprotein Apheresis and Proprotein Convertase Subtilisin/Kexin Type 9 Inhibitors in Patients With Heterozygous Familial Hypercholesterolemia: A One Center Study.” Journal of cardiovascular pharmacology and therapeutics, vol. 26, 2021, pp. 51–58. http://access.bl.uk/ark:/81055/vdc_100114774704.0x00000f